1. Rowland M. (1973): Effect of some physiologic factors on bioavailability of oral dosage forms. In: Current Concepts in the Pharmaceutical Sciences: Dosage form Design and Bioavailability. Philadelphia: Lea and Febiger, 181–222.
2. Wagner J.G. (1988): Effect of first-pass Michaelis-Menten metabolism on performance of controlled release dosage forms. In: Yacobi A., Halperin-Waley E. (Eds) Oral Sustained Release Formulations: Design and Evaluation. New York: Pearl-River, 95–124.
3. Paterson J.W., Woolcock A.J., Shenfield G.M. (1979): Bronchodilator drugs. Am. Rev. Respir. Dis., 120, 1149–1188.
4. Rachelefsky G.S., Siegel S.C. (1985): Asthma in infants and children-treatment of child-hood asthma. J. Allergy Clin. Immunol., 76, 409–425.
5. Eraker S.A., Kirscht J.P., Becker M.H. (1984): Understanding and improving patient compliance. Ann. Intern. Med., 100, 258–268.